Quest Diagnostics, Montefiore Health Systems Partner
Quest Diagnostics is working with Montefiore Health System to provide diagnostic laboratory services. This partnership will enhance the quality and efficiency of laboratory services at Montefiore.
"We are pleased to partner with Montefiore, a premiere academic health system recognized for personalized, accountable care," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics. "As part of our strategy to accelerate growth and drive operational excellence, Quest is collaborating with an increasing number of hospital partners, including leading academic institutions like Montefiore, which are looking to focus on their core business by taking advantage of our expertise, innovation and scale."
Quest will perform a portion of low complexity diagnostic tests at its Teterboro, NJ lab facility. The remainder of the laboratory testing will continue to be done at Montefiore Hospitals under the direction of the Montefiore and Einstein Department of Pathology.
"Quest is a unique company committed to innovating new technologies and diagnostic capabilities," said Philip Ozuah, M.D., Ph.D., and Chief Operating Officer, Montefiore Health System. "Most importantly, this new venture will allow Montefiore to maintain its laser focus on improving patient care and outcomes, while teaming up with a leader in the field who has access to the most sophisticated diagnostic equipment available."
FDA Approves First Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer TherapiesNews
Oncomine Dx Target Test returns results in days, helping physicians rapidly develop treatment plans for the most common form of lung cancer.
BMS, QIAGEN Partner to Develop Gene Expression Profiles for Immuno-OncologyNews
QIAGEN and Bristol-Myers Squibb intend to develop GEPs for several Bristol-Myers Squibb I-O molecules under the initial agreement.READ MORE
A New Test to Detect Anti-phospholipid Antibody SyndromeNews
Researchers have succeeded in identifying the exact spot where anti-phospholipid antibodies attach themselves, enabling the development of a more accurate and standardized diagnostic test.READ MORE